DCM
DAFNA Capital Management Portfolio holdings
AUM
$431M
1-Year Est. Return
68.38%
This Fund
S&P 500
1 Year Est. Return
+68.38%
AUM
$431M
AUM Growth
+$25.7M
(+6.4%)
Holding
87
Top Buys
| 1 | +$8.92M | |
| 2 | +$3.98M | |
| 3 | +$2.93M | |
| 4 |
Denali Therapeutics
DNLI
|
+$2.53M |
| 5 |
MPLT
MapLight Therapeutics
MPLT
|
+$2.41M |
Top Sells
| 1 | +$20.8M | |
| 2 | +$7.45M | |
| 3 | +$6.53M | |
| 4 |
iShares Biotechnology ETF
IBB
|
+$5.59M |
| 5 |
Arcus Biosciences
RCUS
|
+$4M |
Sector Composition
| 1 | Healthcare | 86.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Perspective Therapeutics
CATX
$615M
| $138K | 0.03% |
+50,000
|
|
||
77
Aprea Therapeutics
APRE
$6.41M
| – | – |
-137,174
|
|
||
78
Black Diamond Therapeutics
BDTX
$141M
| – | – |
-307,070
|
|
||
79
Compass Therapeutics
CMPX
$1B
| – | – |
-946,661
|
|
||
80
Keros Therapeutics
KROS
$432M
| – | – |
-80,716
|
|
||
81
Korro Bio
KRRO
$114M
| – | – |
-60,804
|
|
||
|
MRUS
82
DELISTED
Merus
MRUS
| – | – |
-220,451
|
|
||
83
BiomX
PHGE
$6.96M
| – | – |
-21,112
|
|
||
84
Soleno Therapeutics
SLNO
$2.1B
| – | – |
-53,000
|
|
||
85
Sutro Biopharma
STRO
$335M
| – | – |
-43,708
|
|
||
86
UroGen Pharma
URGN
$1.02B
| – | – |
-27,515
|
|